Kalaris Therapeutics Inc. Common Stock (KLRS)
FairStock Score: 64/100 — STEADY
| Current Price | $6.08 |
| Market Cap | $13,94,52,240 |
| P/E Ratio | — |
| ROE | -308.1% |
| Dividend Yield | —% |
| Sector | Healthcare |
Data from SEC filings. Not investment advice. Scoring methodology
FairStock Score: 64/100 — STEADY
| Current Price | $6.08 |
| Market Cap | $13,94,52,240 |
| P/E Ratio | — |
| ROE | -308.1% |
| Dividend Yield | —% |
| Sector | Healthcare |
Data from SEC filings. Not investment advice. Scoring methodology